[Ad hoc announcement pursuant to Art. 53 LR] Roche records solid results for the first nine months of 2022
Basel, 18 October 2022Group salesup 2%1 at constant exchange rates (CER) and 1% in Swiss francs; as expected, significantly lower COVID-19-related sales in both divisions in the third quarterSales in the Pharmaceuticals Divisionat the previous year ’s level with significantly lower sales of COVID-19-related products (Ronapreve and Actemra/RoActemra) and losses to biosimilars, offset by strong growth of newer medicinesSales in the Diagnostics Divisionrise 6%; base business remains strong; as expected, demand for COVID-19 tests sharply down in third quarterHighlights in the third quarter:EU approval forVabysmo (severe eye ...
Source: Roche Media News - October 18, 2022 Category: Pharmaceuticals Source Type: news
Prepare for a challenging flu season: Get vaccinated now
Flu season usually peaks in winter; however, the best time to prevent infection is before the virus appears in a community. "The best time to protect yourself against influenza is before we see it start circulating in large amounts," says Dr. Nipunie Rajapakse, a pediatric infectious diseases physician with the Mayo Clinic Children's Center. "We are starting to detect cases in different parts of the country." The Centers for Disease Control and Prevention reports influenza A… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 18, 2022 Category: Databases & Libraries Source Type: news
FDA Awards Kemp Proteins Contract to Develop Monoclonal Antibodies for...
The FDA’s Laboratory of DNA Viruses will use the antibodies in the design of in-vitro assays for potency release of SARS-CoV-2 and Influenza vaccines.(PRWeb October 17, 2022)Read the full story at https://www.prweb.com/releases/fda_awards_kemp_proteins_contract_to_develop_monoclonal_antibodies_for_sars_cov_2_and_influenza_vaccine_potency_assays/prweb18961008.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 17, 2022 Category: Pharmaceuticals Source Type: news
With Tough Flu Season Already Here, An Expert Answers Your Flu Shot Questions
FRIDAY, Oct. 14, 2022 -- Indications are that this year ’s flu season is going to be particularly nasty, making the annual influenza vaccine even more important than usual, infectious disease experts say.
People already are landing in the hospital... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 14, 2022 Category: General Medicine Source Type: news
Protecting against influenza: A conversation with David Ross, Vice President, Commercial Operations, North America, CSL Seqirus
Our industry is at the forefront of fighting the annual influenza virus. I recently had the chance to connect with David Ross, Vice President, Commercial Operations, North America, CSL Seqirus about how the industry is working to fight the annual flu and what lessons learned during COVID-19 are allowing us to better respond to influenza. (Source: The Catalyst)
Source: The Catalyst - October 13, 2022 Category: Pharmaceuticals Authors: Mike Ybarra Tags: PhRMA Member Company Vaccines Infectious Diseases Coronavirus Source Type: news
We May Be in for Yet Another COVID-19 Surge This Fall and Winter
Fall and winter have always been peak seasons for respiratory viruses. As the weather cools in many parts of the U.S., people are forced into indoor environments where viruses can spread more easily. Holiday gatherings and travel can also become breeding grounds for disease.
That’s one reason why experts are worried that COVID-19 case counts may rise in the U.S. in the coming weeks. But there’s also another. To help forecast COVID-19 rates for the U.S., experts often look to Europe—and the data there aren’t promising. More than 1.5 million COVID-19 diagnoses were reported across Europe during the we...
Source: TIME: Health - October 11, 2022 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
What Happens If I Get COVID-19 and the Flu at the Same Time?
So far, COVID-19 has come with one small silver lining for health: cases of influenza have dropped dramatically. During the first flu season during the pandemic, lockdowns kept people indoors and away from one another, limiting the virus’ ability to spread. And once people began mingling more during the next flu seasons, widespread use of masks blocked influenza’s chances of infecting large numbers of people.
But that could change this flu season, as mask mandates have disappeared and more people are interacting in close quarters in school, workplaces, sports events, public transport, and more. Health experts a...
Source: TIME: Health - October 11, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Panacea wins contract worth $127 million from WHO, PAHO to supply pentavalent vaccine
The vaccine protects children against five deadly diseases: Diphtheria, Tetanus, Pertussis, Hepatitis B and invasive infections caused by Haemophilus Influenza Type b. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 10, 2022 Category: Pharmaceuticals Source Type: news
Influenza Activity and Composition of the 2022-23 Flu Vaccine Influenza Activity and Composition of the 2022-23 Flu Vaccine
Review the 2021-22 influenza season and get a preview of the composition of the 2022-23 vaccines in this report.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 7, 2022 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news
QuickStats: Percentage of Residential Care Communities that Offer Annual Influenza Vaccination to Residents and to Employees and Contract Staff Members, by Community Bed Size - United States, 2020
This report describes the percentage of residential care communities that offer annual flu vaccination to residents and employees. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - October 6, 2022 Category: American Health Tags: Influenza Vaccination MMWR Morbidity & Mortality Weekly Report Vaccines Nursing Homes Assisted Living Facilities Source Type: news
Influenza Survey: Only 49% Of U.S. Adults Plan On Getting Vaccine, 58% May Mask
The National Foundation for Infectious Diseases (NFID) survey also revealed the reasons why over half of the respondents won't be getting vaccinated against influenza. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 6, 2022 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news
Despite Potentially Worse Flu Season, Only 49% Of U.S. Adults Plan To Get Vaccine
The National Foundation for Infectious Diseases (NFID) survey also revealed the reasons why over half of the respondents won't be getting vaccinated against influenza. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 6, 2022 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news
Consumer Health: What you need to know about flu vaccination if you have cancer
As flu season approaches, it's important to understand the need to get vaccinated for influenza, or flu. Indications are it could be a different flu season than what the U.S. experienced the past two years. If you have cancer, it's especially important that you protect yourself from the flu. The Centers for Disease Control and Prevention recommends a yearly flu vaccination for everyone 6 months and older, with rare exceptions. While it's not 100% effective, vaccination… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 6, 2022 Category: Databases & Libraries Source Type: news
AHN Administers Updated Moderna and Pfizer COVID-19 Boosters
Network’s Clinicians Also Encourage Annual Influenza Vaccinations as Flu Season Arrives(PRWeb October 05, 2022)Read the full story at https://www.prweb.com/releases/ahn_administers_updated_moderna_and_pfizer_covid_19_boosters/prweb18938037.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 5, 2022 Category: Pharmaceuticals Source Type: news
Two Are Better Than One: Expanding Our Covid-19 Vaccine Antigens
Like influenza, SARS-CoV-2 is an expert at mutating and evading prior immunity. This includes vaccine-induced immunity. New research suggests that expanding the target area of our vaccines to include the virus' nucleocapsid protein may offer stronger and broader protection. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 3, 2022 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation Coronavirus business pharma & Source Type: news
